SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Seres Therapeutics Q2 EPS $(0.28) Down From $(0.24) YoY, Sales $6.04M Down From $12.53M YoY

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.28) per share. This is a 16.67 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $6.04 million in

Benzinga · -
Seres Therapeutics (NASDAQ: MCRB) reported quarterly losses of $(0.28) per share. This is a 16.67 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $6.04 million in sales this quarter. This is a 51.76 percent decrease over sales of $12.53 million the same period last year.